...
Standard | Fit for Purpose | Stewardship | Quality | |||||
Fits | Implementation | Vendor Support | Canadian | SDO | Complexity | Standard | Training, Support and Tooling | |
CeRx HL7 V3.0 - Immunizations | Production in Canada | Yes | Yes | High | ||||
HLv2 | Not used | No | Yes | High | ||||
Architectural Constraints and Considerations | Secondary Benefits | |||||||
The Canadian HL7 V3 CeRx specification was designed to support the in scope use cases in a manner consistent with the design principles of Canada's digital health blueprint. The CeRx specification is widely adopted for drug domain messaging. | Version 3 uses rigorous analytic and message building techniques and eliminates areas of optionality that could negatively impact semantic interoperability. | |||||||
Recommendation | Supporting Rationale | |||||||
CeRx implementers may use the latest CeRx specification for immunization messaging. (Note that the newer HL7 v3 public health messaging supports a broader range of transactions.) | The specification was designed to meet the in-scope use cases and conforms with the architectural design of Canada's digital health blueprint. |